Playback speed
10 seconds
Final 48-Week Results of the APPLY-PNH Trial: Long-Term Efficacy & Safety in Anti-C5-Treated Patients With PNH & Persistent Anemia Undergoing Factor B Inhibition With Oral Iptacopan Monotherapy
By
Insights from 2023 ASH Annual Meeting
FEATURING
Carlos de Castro
By
Insights from 2023 ASH Annual Meeting
FEATURING
Carlos de Castro
0 views
April 3, 2024
Comments 0
Login to view comments.
Click here to Login